NCT02101853-D4
Dataset Information
Dataset ID: NCT02101853-D4
PubMed ID (PMID):
Publication Title:
Children’s Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
Description of Dataset:
NCT02101853-D4: There are a total of 2 datasets associated with the PubMed 37257143: NCT02101853-D3 through NCT02101853-D4. This dataset, NCT02101853-D4, is required for providing specific incidence of adverse events of interest. Adverse events (AE) that occurred with a grade of 3 or above at a frequency of 5% or greater in at least one course of interest for the patients in the primary analysis are included. There are multiple rows per patient depending on the number of courses administered. Each column corresponds to a single AE event, either any grade or grade 3 or above. Additional data from the high and intermediate risk cohorts presented in PMID 33651090 can be found in NCT02101853-D1 and NCT02101853-D2.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
NCT Trial Number | Disease Type |
---|---|
NCT02101853 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®